Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer.
Shinohara H, Kobayashi M, Hayashi K, Nogawa D, Asakawa A, Ohata Y, Kubota K, Takahashi H, Yamada M, Tokunaga M, Kinugasa Y, Oda G, Nakagawa T, Onishi I, Kinowaki Y, Kurata M, Ohashi K, Kitagawa M, Yamamoto K.
Shinohara H, et al. Among authors: kinugasa y.
Int J Mol Sci. 2022 Oct 31;23(21):13235. doi: 10.3390/ijms232113235.
Int J Mol Sci. 2022.
PMID: 36362023
Free PMC article.